ABSTRACT
OBJECTIVE: Prediction of post-extubation stridor (PES) after thyroid surgeries has been challenging, and many criteria such as preoperative clinical parameters and intraoperative cuff leak test (CLT) have been used with variable results. The application of laryngeal ultrasound in predicting PES is a relatively new and non-invasive technique. Measurement of the air column width difference (ACWD) by laryngeal ultrasonography can predict PES. This study aimed to evaluate the efficacy of laryngeal ultrasound in the prediction of PES in patients after thyroidectomy and compare it with that of the CLT. METHODS: A total of 200 patients who had undergone total thyroidectomy under general anaesthesia in a tertiary healthcare hospital were enrolled in the study. At the end of the surgery, air column widths (ACWs) were measured during endotracheal cuff inflation and deflation using laryngeal ultrasound in patients with spontaneous breathing. ACWD was measured and compared with that of the CLT at the time of extubation to predict PES. RESULTS: A total of 12 (6%) patients developed PES. ACWD using laryngeal ultrasound and CLT showed high sensitivity (91.7% and 92.6%, respectively), specificity (91.7% and 90.4%, respectively) and negative predictive value (99.43% and 99.42%, respectively) with low positive predictive value (44% and 37.93%, respectively) for both the diagnostic tests. CONCLUSION: Application of laryngeal ultrasound in combination with CLT can help the anaesthesiologist in decision making with the extubation plan after thyroid surgeries.
ABSTRACT
OBJECTIVE: To determine the effectiveness of gabapentin as an add-on therapy in children presenting with overactive bladder (OAB) not responding to conventional anticholinergics. MATERIALS AND METHODS: Children with refractory OAB were included prospectively from March 2009 to February 2010. The inclusion criterion was persistence of symptoms while on conventional anticholinergics for 6 months. Gabapentin was prescribed as an add-on therapy. The patients were followed 4 weekly with bladder diary and urodynamic study was repeated at 3 months. RESULTS: There were 31 children, 26 of neurogenic OAB and 5 of non-neurogenic origin. Mean ± SD age was 8.5 ± 5.3 years. Data were analyzed in 30 patients as treatment was terminated in 1 due to adverse effects. Continence improved in 16 (53.3%) patients. Voiding volume improved from 175 ± 90 to 320 ± 110 ml (p<0.03). Objective assessment of OAB symptom relief showed marked improvement (p<0.05). Mean maximum cystometric bladder capacity improved from 210 ± 94 to 360 ± 110 ml (p<0.02). The maximal detrusor contraction decreased from 75 ± 35 to 25 ± 15 cmH(2)O (p<0.02). Fourteen patients (46.7%) failed to respond to gabapentin therapy. These patients had baseline maximum cystometric bladder capacity <60% for age and maximum detrusor contractions >50 cm of water (p<0.03). CONCLUSIONS: Gabapentin gives moderate results in children with OAB refractory to conventional anticholinergics. In general, the drug is well tolerated with fewer adverse effects.
